gastroparesis symptoms glp 1 GLP-1 Risk: What Patients Need to Know How Dangerous Is Gastroparesis? |

Takaaki Kanemaru (Department of Morphology Core Unit, Kyushu University Hospital) and The Research Support Center, Research Center for Human Disease Modeling, Kyushu University Graduate School of Medical Sciences, which is partially supported by the Mitsuaki Shiraishi Fund for Basic Medical Research

Ditch the "just do Kegels" mentality: Not every woman should do Kegel exercises

With more and more cardioprotective agents on board and with the pursuit of ambitious targets, further risk reduction may be harder to achieve

Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor with an unusual profile for the treatment of type 2 diabetes

Glucagon-like peptide-1 receptor agonists: a narrative review of clinical pharmacology and implications for peri-operative practice